Omada Health, Inc.
OMDAHealthcareNASDAQHealth Information Services · Last scanned Jul 17, 2026
Scan Results
Daily timeframeOmada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company carries a $1.41B market cap, placing it firmly in the small-cap category. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Market Cap
$1.41B
Beta
—
P/E (TTM)
—
P/E (Fwd)
49.96
EPS (TTM)
$-0.23
EPS (Fwd)
$0.47
ROE
-4.3%
ROA
-2.4%
Cash
$211.8M
Total Debt
$0
Free CF
$16.8M
52W Change
33.8%
Annual Financials
Cash vs Debt
Omada Health, Inc. reports $211.8M in cash and $0 in total debt. Free cash flow comes in at $16.8M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -4.3%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $89.2M (2022) to $260.2M (2025), reflecting a 192% increase over the period.
Investors considering Omada Health, Inc. should weigh the typical risks associated with OMDA's sector, size, and financial profile against their own risk tolerance and investment objectives. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Omada Health, Inc.'s trajectory.